Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

Recruiting Observational Study
Von Willebrand Diseases
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
University Hospital, Brest · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Due to increasing of life expectancy, patients with von Willebrand disease are exposed to age-related pathologies such as cancer or cardiovascular diseases. Management of thrombotic events is challenging given the inherent bleeding risk in von Willebrand disease. Few data are currently available in the literature. The aim of the study is to describe the frequency and nature of arterial and venous…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Von Willebrand disease * Adult * Followed-up in a reference center of West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers) * Consented to be included in BERHLINGO database * Have presented a thrombotic and/or embolic event or cardiovascular disease including deep vein…
Contacts

Brigitte PAN PETESCH

02.98.22.36.50

brigitte.pan-petesch@chu-brest.fr

CONTACT

Sara ROBIN

sara.robin@chu-brest.fr

CONTACT